Harbor Clinical

Executive Summary

Harbor Clinical is a private Clinical Research Organization (CRO) headquartered in San Diego with global operations across Europe, APAC, and the Americas. Founded in 2017, the company offers a suite of software solutions and a highly specialized international team to support clinical trial needs. With offices in Boston, Sofia, Hyderabad, and other locations, Harbor Clinical leverages its distributed workforce to provide cost-effective and efficient trial management services. The company operates at the intersection of diagnostics and digital health, positioning itself to capitalize on the growing demand for decentralized and technology-enabled clinical trials. While specific financial and funding details are not public, Harbor Clinical's broad geographic footprint and focus on integrated software suggest a scalable business model. The company's recent profile enrichment and inclusion in industry directories indicate active market presence, but limited public information constrains a full assessment of its competitive positioning and growth trajectory.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Clinical Trial Management Platform70% success
• TBDStrategic Partnership with a Major Pharmaceutical Firm for Late-Stage Trials60% success
• Q3 2026Expansion into New Geographic Markets (e.g., Latin America or Southeast Asia)65% success